4
Changes in Ownership
Emmaus Life Sciences, Inc. Filed Acc 0001615774-16-007357
Director acquired 114,074 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| FOLLMAN ROBERT J Director | 2016-09-21 | Option exercise | +114,074 | $5.00 | $570,370 | 147,781 | I |
| Derivatives | |||||||
| FOLLMAN ROBERT J Director | 2016-09-21 | Option exercise · 5% Secured Convertible Note due December 2017 | −0 | I | |||
| FOLLMAN ROBERT J Director | 2016-09-21 | Returned to the company · Common Stock Warrant | −0 | 0 | I | ||
Loading xslF345X03/s104198_from4.xml…